- Home
- OGEN vs AEMD Comparison
OGEN vs AEMD Comparison
Compare OGEN & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- AEMD
- Stock Information
- Founded
- OGEN 1996
- AEMD 1984
- Country
- OGEN United States
- AEMD United States
- Employees
- OGEN N/A
- AEMD N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- AEMD Medical/Dental Instruments
- Sector
- OGEN Health Care
- AEMD Health Care
- Exchange
- OGEN Nasdaq
- AEMD Nasdaq
- Market Cap
- OGEN 5.5M
- AEMD 5.0M
- IPO Year
- OGEN N/A
- AEMD N/A
- Fundamental
- Price
- OGEN $0.28
- AEMD $0.71
- Analyst Decision
- OGEN
- AEMD Strong Buy
- Analyst Count
- OGEN 0
- AEMD 1
- Target Price
- OGEN N/A
- AEMD $7.00
- AVG Volume (30 Days)
- OGEN 507.3K
- AEMD 1.3M
- Earning Date
- OGEN 03-28-2025
- AEMD 02-12-2025
- Dividend Yield
- OGEN N/A
- AEMD N/A
- EPS Growth
- OGEN N/A
- AEMD N/A
- EPS
- OGEN N/A
- AEMD N/A
- Revenue
- OGEN N/A
- AEMD N/A
- Revenue This Year
- OGEN N/A
- AEMD N/A
- Revenue Next Year
- OGEN N/A
- AEMD N/A
- P/E Ratio
- OGEN N/A
- AEMD N/A
- Revenue Growth
- OGEN N/A
- AEMD N/A
- 52 Week Low
- OGEN $0.25
- AEMD $0.24
- 52 Week High
- OGEN $4.00
- AEMD $1.85
- Technical
- Relative Strength Index (RSI)
- OGEN 41.56
- AEMD 51.85
- Support Level
- OGEN $0.34
- AEMD $0.62
- Resistance Level
- OGEN $0.32
- AEMD $0.78
- Average True Range (ATR)
- OGEN 0.03
- AEMD 0.06
- MACD
- OGEN 0.00
- AEMD -0.01
- Stochastic Oscillator
- OGEN 41.80
- AEMD 34.18
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.